Torgeir Wethal

1.1k total citations
27 papers, 805 citations indexed

About

Torgeir Wethal is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Torgeir Wethal has authored 27 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Torgeir Wethal's work include Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac Imaging and Diagnostics (5 papers). Torgeir Wethal is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac Imaging and Diagnostics (5 papers). Torgeir Wethal collaborates with scholars based in Norway, Netherlands and United States. Torgeir Wethal's co-authors include Sophie D. Fosså, Hege Sagstuen Haugnes, Roy M. Bremnes, Tom Wilsgaard, Olbjørn Klepp, Olav Dahl, Carl W. Langberg, Nina Aass, Alexander Fosså and Thor Edvardsen and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Stroke.

In The Last Decade

Torgeir Wethal

23 papers receiving 782 citations

Peers

Torgeir Wethal
Mehul Patel United States
Robert W. Burt United States
Wallace W. Peck United States
C F Bekdik Türkiye
Klaus Pietzner Germany
Takuro Isoda Japan
Hani Rashid United States
Güler Yavaş Türkiye
Ajay Agarwal United States
Lucy Davies Australia
Mehul Patel United States
Torgeir Wethal
Citations per year, relative to Torgeir Wethal Torgeir Wethal (= 1×) peers Mehul Patel

Countries citing papers authored by Torgeir Wethal

Since Specialization
Citations

This map shows the geographic impact of Torgeir Wethal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torgeir Wethal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torgeir Wethal more than expected).

Fields of papers citing papers by Torgeir Wethal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torgeir Wethal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torgeir Wethal. The network helps show where Torgeir Wethal may publish in the future.

Co-authorship network of co-authors of Torgeir Wethal

This figure shows the co-authorship network connecting the top 25 collaborators of Torgeir Wethal. A scholar is included among the top collaborators of Torgeir Wethal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torgeir Wethal. Torgeir Wethal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hageman, Steven H J, Jannick A N Dorresteijn, Frank L.J. Visseren, et al.. (2025). External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients. European Journal of Preventive Cardiology. 33(4). 500–510.
2.
3.
Vinje, Vegard, Steven H J Hageman, Jannick A N Dorresteijn, et al.. (2024). External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment. European Heart Journal. 45(Supplement_1).
4.
Aam, Stina, Stian Lydersen, Per Magne Ueland, et al.. (2024). Neopterin, kynurenine metabolites, and indexes related to vitamin B6 are associated with post-stroke cognitive impairment: The Nor-COAST study. Brain Behavior and Immunity. 118. 167–177. 3 indexed citations
5.
6.
Aam, Stina, Torunn Askim, Mona K. Beyer, et al.. (2023). Plasma Inflammatory Biomarkers Are Associated With Poststroke Cognitive Impairment: The Nor-COAST Study. Stroke. 54(5). 1303–1311. 20 indexed citations
7.
Giskeødegård, Guro F., Torfinn Støve Madssen, Matteo Sangermani, et al.. (2022). Longitudinal Changes in Circulating Metabolites and Lipoproteins After Breast Cancer Treatment. Frontiers in Oncology. 12. 919522–919522. 4 indexed citations
8.
Ellekjær, Hanne, et al.. (2021). ABCD3-I and ABCD2 Scores in a TIA Population with Low Stroke Risk. Stroke Research and Treatment. 2021. 1–8. 4 indexed citations
9.
Gulati, Geeta, Siri Lagethon Heck, Espen Holte, et al.. (2021). Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial. Cardio-Oncology. 7(1). 33–33. 26 indexed citations
10.
Hageman, Steven H J, Jannick A N Dorresteijn, Olav Spigset, et al.. (2021). Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention. Clinical Epidemiology. Volume 13. 813–823. 7 indexed citations
11.
Ellekjær, Hanne, Torgeir Wethal, Stian Lydersen, et al.. (2019). Stroke risk after transient ischemic attack in a Norwegian prospective cohort. BMC Neurology. 19(1). 2–2. 14 indexed citations
12.
Murbræch, Klaus, Torgeir Wethal, Knut B. Smeland, et al.. (2016). Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation. JACC. Cardiovascular imaging. 9(3). 230–239. 36 indexed citations
13.
Stenehjem, Jo S, Knut B. Smeland, Klaus Murbræch, et al.. (2016). Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation. Bone Marrow Transplantation. 52(4). 646–649. 5 indexed citations
14.
Wethal, Torgeir, Ragnhild Røysland, Torbjørn Omland, & John Kjekshus. (2015). Exercise-induced vasodilation in healthy males: A marker of reduced endothelial function. Scandinavian Cardiovascular Journal. 49(3). 123–129. 1 indexed citations
15.
Wethal, Torgeir, Bård Nedregaard, Rune Andersen, et al.. (2013). Atherosclerotic lesions in lymphoma survivors treated with radiotherapy. Radiotherapy and Oncology. 110(3). 448–454. 21 indexed citations
16.
Gjesdal, Ola, Torgeir Wethal, Kristina H. Haugaa, et al.. (2011). Left Ventricular Function Assessed by Two-Dimensional Speckle Tracking Echocardiography in Long-Term Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy With or Without Anthracycline Therapy. The American Journal of Cardiology. 107(3). 472–477. 82 indexed citations
17.
Wethal, Torgeir, Hege Sagstuen Haugnes, John Kjekshus, et al.. (2010). C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?. European Journal of Cancer. 46(18). 3425–3433. 15 indexed citations
18.
Andersen, Rune, Torgeir Wethal, Anne Günther, et al.. (2009). Relation of Coronary Artery Calcium Score to Premature Coronary Artery Disease in Survivors >15 Years of Hodgkin's Lymphoma. The American Journal of Cardiology. 105(2). 149–152. 40 indexed citations
19.
Wethal, Torgeir, Thor Edvardsen, Sophie D. Fosså, et al.. (2009). Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study. British Journal of Cancer. 101(4). 575–581. 83 indexed citations
20.
Wethal, Torgeir, John Kjekshus, Jo Røislien, et al.. (2007). Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer. Journal of Cancer Survivorship. 1(1). 8–16. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehul Patel Breakdown of academic impact, for papers by Robert W. Burt Breakdown of academic impact, for papers by Wallace W. Peck Breakdown of academic impact, for papers by C F Bekdik Breakdown of academic impact, for papers by Klaus Pietzner Breakdown of academic impact, for papers by Takuro Isoda Breakdown of academic impact, for papers by Hani Rashid Breakdown of academic impact, for papers by Güler Yavaş Breakdown of academic impact, for papers by Ajay Agarwal Breakdown of academic impact, for papers by Lucy Davies
Rankless by CCL
2026